Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP

Molecular Carcinogenesis

Volumn 33, Issue 2, 2002, Pages 88-98

  Goodin, Jeremy L ^a   Rutherford, Charles L ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Differential display polymerase chain reaction; Prostate cancer; Signal transduction

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; CYCLIC AMP; PHOSPHODIESTERASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DATA BASE; DIFFERENTIAL DISPLAY; DNA SEQUENCE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEUROSECRETORY CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CYCLIC AMP; DNA, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0036154318     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10025     Document Type: Article

References (47)

1. Molecular and cellular biology of prostate cancer
2. Androgen signal transduction and prostatic carcinoma
3. The LNCaP cell line: A new model for studies on human prostatic carcinoma
4. LNCaP model of human prostatic cacinoma
5. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP
6. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: Implications for prostate cancer progression
7. Activated 3′,5′-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line
8. Neuroendocrine differentiation in prostatic carcinoma
9. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells
10. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells
11. The neuroendocrine cell population of the human prostate gland
12. The prostatic endocrineparacrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: A review and future directions in basic research
13. Neuroendocrine differentiation in prostatic carcinoma
14. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
15. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
16. Differential display using one-base anchored oligo-dT primers
17. Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimizations
18. Recent advances in differential display
19. Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer
20. Differentially expressed genes in androgen-dependent and-independent prostate carcinomas
21. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression coning and differential RNA display
22. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
23. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
24. Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria
25. The S3a ribosomal protein gene is identical to the Fte-1 (v-fos transformation effector) gene and the TNF-alpha-induced TU-11 gene, and its transcript level is altered in transformed and tumor cells
26. Ribosomal protein genes are overexpressed in colorectal cancer: Isolation of a cDNA clone encoding the human S3 ribosomal protein
27. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma
28. Down regulation of ribosomal protein mRNAs during neuronal differentiation of human NTERA2 cells
29. The structure and function of initiation factors in eukaryotic protein synthesis
30. Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression
31. Novel interaction between the transcription factor CHOP (GADD153) and the ribosomal protein FTE/S3a modulates erythropoiesis
32. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
33. Expression of glypican 3 (GPC3) in embryonal tumors
34. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma
35. Frequent silencing of the GPC3 gene in ovarian cancer cell lines
36. Angiostatin binds ATP synthase on the surface of human endothelial cells
37. Molecular characterization of a newly identified heme-binding protein induced during differentiation of urine erythroleukemia cells
38. Structure, turnover, and heme-mediated suppression of the level of mRNA encoding rat liver delta-aminolevulinate synthase
39. Derepression of ferritin messenger RNA translation by hemin in vitro
40. The biological properties and evolutionary dynamics of mammalian LINE-1 retrotransposons
41. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis
42. A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease
43. Human LINE retrotransposons generate processed pseudogenes
44. Characterization of the primate-specific repetitive DNA element MER1
45. Effects of Alu insertions on gene function
46. Coordinated posttranscriptional control of gene expression by modular elements including Alu-like repetitive sequences